Eleven Biotherapeutics' eye drug fails late-stage study
January 15, 2016 at 16:16 PM EST
Jan 15 (Reuters) - Eleven Biotherapeutics Inc said its lead eye drug failed in a late-stage trial in treating patients with severe allergic conjunctivitis.
